Article
Studies on natural killer cells in chronic myeloid leukemia patients in remission.
Neoplasma - 1 Jan 1990
Dabholkar M, Tatake R J, Advani S, Gangal S G
Abstract excerpt
In our earlier studies, the natural killer (NK) cell mediated cytotoxicity was found to be impaired in 55% of chronic myeloid leukemia (CML) patients in remission (low NK responders), while the rest exhibited normal range of cytotoxicity (normal NK responders). In the present investigations proba...
Topics
- Antigens, Differentiation
- Antigens, Differentiation, T-Lymphocyte
- CD57 Antigens
- CD8 Antigens
- Cell Fractionation
- Humans
- Killer Cells, Natural
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Phenotype